Biocept 'one of the first' liquid biopsy providers to detect cancer biomarkers in fluid around brain

Biocept Inc (NASDAQ:BIOC) CEO Mike Nall tells Proactive the California-based company's Target Selector liquid biopsy tests are now available to detect cancer biomarkers in cerebrospinal fluid.

Nall says the company has also managed to win a US patent for its liquid biopsy cancer testing technology.

brain